TABLE 3.
Sensitivity | Specificity | Number recommended for TB therapy based on Ultra result (yield) | |||
---|---|---|---|---|---|
|
|
||||
n/N | % (95% CI) | n/N | % (95% CI) | ||
Ultra Trace call result considered negative (all considered negative) | |||||
All | 73/92 | 79.3 (69.6–87.1) | 643/648 | 99.2 (98.2–99.7) | 78 |
Smear-positive | 45/46 | 97.8 (88.5–99.9) | 1/2 | 50.0 (1.26–98.7) | 46 |
Smear-negative | 28/46 | 60.9 (45.4–74.9) | 641/645 | 99.4 (98.4–99.8) | 32 |
Ultra Trace call result considered positive (according to original WHO guidance)* | |||||
All | 74/92 | 80.8 (70.9–88.0) | 627/648 | 96.8 (95.1–98.0) | 95 |
Smear-positive | 45/46 | 97.8 (86.0–99.5) | 1/2 | 50.0 (1.3–98.7) | 46 |
Smear-negative | 29/46 | 63.0 (47.5–76.8) | 625/645 | 96.9 (95.3–98.1) | 49 |
Ultra Trace call result considered positive (according to current WHO guidance)† | |||||
All | 76/92 | 82.6 (73.3–89.7) | 611/648 | 94.3 (92.2–95.9) | 113 |
Smear-positive | 45/46 | 97.8 (88.5–99.9) | 1/2 | 50.0 (1.3–98.7) | 46 |
Smear-negative | 31/46 | 67.4 (52.0–80.5) | 609/645 | 94.5 (92.4–96.1) | 67 |
Ultra Trace call result considered positive (all considered positive) | |||||
All | 76/92 | 82.6 (73.3–89.7) | 608/647 | 94.0 (91.9–95.7) | 115 |
Smear-positive | 45/46 | 97.9 (88.5–99.9) | 1/2 | 50.0 (1.3–98.7) | 46 |
Smear-negative | 31/46 | 67.4 (52.0–80.5) | 607/645 | 94.1 (92.0–95.8) | 69 |
*Trace call result considered a true positive result for HIV-positive persons and a false-positive result for HIV-negative persons.
†Trace call result considered a true-positive result for HIV-positive persons and HIV-negative persons not previously treated for TB and a false-positive result for HIV-negative persons with a prior history of TB.
CI = confidence interval.